medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Number 1

<< Back Next >>

Rev Nefrol Dial Traspl 2021; 41 (1)

Magnesium Levels in Children with Chronic Kidney Disease Stages 1-3

Yilmaz K, Dursun I, Dusunsel R, Gunduz Z, Yel S

Language: English
References: 26
Page: 36-41
PDF size: 216.66 Kb.


ABSTRACT

Objective: The objective of this study was to assess serum and urinary magnesium levels in children who have chronic kidney disease stages 1-3. Methods: Eighty-seven patients who were followed at pediatric nephrology department for chronic kidney disease were included in the study. Age, gender, magnesium, dietary magnesium, and creatinine levels, and fractionated magnesium excretion for all cases were recorded. Patients with chronic kidney disease and control groups were compared in terms of these data. Results: Thirtynine cases with chronic kidney disease were stage 1, 26 were stage 2, and 22 were stage 3. Average age was 9.9 ± 2.8 years in the control group and 10.2 ± 2.6 years in the chronic kidney disease group. The serum magnesium levels were significantly higher in the stage 3 group than in the control group (P‹0.001). Also, in stage 3, fractionated magnesium excretion levels were higher compared to the control group (P‹0.001). Conclusion: In chronic kidney disease with advancing renal failure, hypermagnesemia is frequently seen. Serum magnesium levels should be measured periodically in all the children with chronic kidney disease stage 3 to investigate magnesium abnormalities and assess clinical results.


REFERENCES

  1. Navarro-González JF, Mora-Fernández C, García-Pérez J. Clinical implications of disordered magnesiumhomeostasis in chronic renal failure and dialysis.Semin Dial. 2009;22(1):37-44. doi: 10.1111/j.1525-139X.2008.00530.x.

  2. Massy ZA, Nistor I, Apetrii M, Brandenburg VM,Bover J, Evenepoel P, et al. Magnesium-basedinterventions for normal kidney function and chronickidney disease. Magnes Res. 2016;29(4):126-40. doi:10.1684/mrh.2016.0412.

  3. Stevens PE, Levin A; Kidney Disease: ImprovingGlobal Outcomes Chronic Kidney Disease GuidelineDevelopment Work Group Members. Evaluationand management of chronic kidney disease: synopsisof the kidney disease: improving global outcomes2012 clinical practice guideline. Ann Intern Med.2013;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.

  4. de Francisco ALM, Rodríguez M. Magnesium its rolein CKD. Nefrologia. 2013;33(3):389-99. doi: 10.3265/Nefrologia.pre2013.

  5. Cunningham J, Rodríguez M, Messa P. Magnesium inchronic kidney disease Stages 3 and 4 and in dialysispatients. Clin Kidney J. 2012;5(Suppl. 1):i39-i51. doi:10.1093/ndtplus/sfr166.

  6. Felsenfeld AJ, Levine BS, Rodriguez M. Pathophysiologyof calcium, phosphorus, and magnesium dysregulationin chronic kidney disease. Semin Dial. 2015;28(6):564-

  7. doi: 10.1111/sdi.12411.7) Schwalfenberg GK, Genuis SJ. The importanceof magnesium in clinical healthcare. Scientifica (Cairo).2017;2017:4179326. doi: 10.1155/2017/4179326.

  8. Laires MJ, Monteiro CP, Bicho M. Role of cellularmagnesium in health and human disease. Front Biosci.2004;9:262-76. doi: 10.2741/1223.

  9. Hoorn EJ, Zietse R. Disorders of calcium andmagnesium balance: a physiology-based approach.Pediatr Nephrol. 2013;28(8):1195-206. doi: 10.1007/s00467-012-2350-2.

  10. Wolf MT. Inherited and acquired disorders of magnesiumhomeostasis. Curr Opin Pediatr. 2017;29(2):187-98.doi: 10.1097/MOP.0000000000000450.

  11. Seo JW, Park TJ. Magnesium metabolism.Electrolyte Blood Press. 2008;6(2):86-95. doi: 10.5049/EBP.2008.6.2.86.

  12. Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y,et al. Serum magnesium, mortality, and cardiovasculardisease in chronic kidney disease and end-stage renaldisease patients: a systematic review and meta-analysis.J Nephrol. 2019;32(5):791-802. doi: 10.1007/s40620-019-00601-6.

  13. Leenders NHJ, Vervloet MG. Magnesium: a magicbullet for cardiovascular disease in chronic kidneydisease? Nutrients. 2019;11(2):455. doi: 10.3390/nu11020455.

  14. Stark CM, Nylund CM, Gorman GH, Lechner BL.Primary renal magnesium wasting: an unusual clinicalpicture of exercise-induced symptoms. Physiol Rep.2016;4(8):e12773. doi: 10.14814/phy2.12773.

  15. Dewitte K, Dhondt A, Giri M, Stöckl D, Rottiers R,Lameire N, et al. Differences in serum ionized andtotal magnesium values during chronic renal failurebetween nondiabetic and diabetic patients: a crosssectionalstudy. Diabetes Care. 2004;27(10):2503-5.doi: 10.2337/diacare.27.10.2503.

  16. Apetrii M, Covic A, Massy ZA. Magnesiumsupplementation: a consideration in dialysis patients.Semin Dial. 2018;31(1):11-14. doi: 10.1111/sdi.12653.

  17. Tsai S, Zhao H, Wu B, Zuo L, Wang M. SerumMagnesium abnormality and influencing factors ofserum magnesium level in peritoneal dialysis patients:a single-center study in northern China. Blood Purif.2018;45(1-3):110-117. doi: 10.1159/000485315.

  18. Assadi F. Hypomagnesemia: an evidence-basedapproach to clinical cases. Iran J Kidney Dis.2010;4(1):13-9.

  19. Laires MJ, Monteiro CP, Bicho M. Role of cellularmagnesium in health and human disease. Front Biosci. 2004;9:262-76. doi: 10.2741/1223.

  20. Yu ASL, Yarlagadda SG. Hypomagnesemia: clinicalmanifestations of magnesium depletion [Internet].En: UpToDate. Disponible en: (consulta:15/13/2020).

  21. 21.Baker SB, Worthley LI. The essentials of calcium,magnesium and phosphate metabolism: part II.Disorders. Crit Care Resusc. 2002;4(4):307-15.

  22. Floege J. Magnesium in CKD: more than acalcification inhibitor? J Nephrol. 2015;28(3):269-77.doi: 10.1007/s40620-014-0140-6.

  23. Cai K, Luo Q, Dai Z, Zhu B, Fei J, Xue C, et al.Hypomagnesemia is associated with increasedmortality among peritoneal dialysis patients. PLoSOne. 2016;11(3):e0152488. doi: 10.1371/journal.pone.0152488.

  24. Toprak O, Kurt H, Sarı Y, Şarkış C, Us H, KırıkA. Magnesium replacement improves the metabolicprofile in obese and pre-diabetic patients with mildto-moderate chronic kidney disease: a 3-month,randomised, double-blind, placebo-controlledstudy. Kidney Blood Press Res. 2017;42(1):33-42. doi:10.1159/000468530.

  25. Yorifuji M, Kuragano T, Kawada S, Fukao W,Toyoda K, Nakanishi T. Factors associated with serummagnesium and vascular stiffness in maintenancehemodialysis patients. Hemodial Int. 2018;22(3):342-50. doi: 10.1111/hdi.12625.

  26. Molnar AO, Biyani M, Hammond I, HarmonJP, Lavoie S, McCormick B, et al. Lower serummagnesium is associated with vascular calcificationin peritoneal dialysis patients: a cross sectional study.BMC Nephrol. 2017;18(1):129. doi: 10.1186/s12882-017-0549-y.




2020     |     www.medigraphic.com